Stroke Severity and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation

Kotaro Watanabe1, Shuhei Okazaki1, Takaya Kitano1

  • 1Department of Neurology, Osaka University Graduate School of Medicine, Osaka, Japan.

Insights

Stroke severity and outcomes are similar for patients with newly diagnosed atrial fibrillation (AF) compared to those with known AF. Early detection of latent AF and anticoagulation are crucial for preventing severe strokes.

Area of Science:

  • Neurology
  • Cardiology
  • Public Health

Background:

  • Atrial fibrillation (AF) is a significant risk factor for severe stroke.
  • Understanding stroke severity differences between newly diagnosed and known AF patients is crucial for risk stratification and management.
  • Existing research has not sufficiently evaluated stroke severity in these distinct AF patient groups.

Purpose of the Study:

  • To compare stroke severity and in-hospital outcomes between patients with newly diagnosed AF and those with known AF.
  • To evaluate the impact of AF diagnosis timing on acute ischemic stroke characteristics.
  • To inform clinical strategies for managing stroke patients with atrial fibrillation.

Main Methods:

  • Retrospective analysis of 196 acute ischemic stroke patients with AF (January 2010 - October 2019).
  • Patients categorized into 'newly diagnosed AF' and 'known AF' groups.
  • Stroke severity assessed by National Institutes of Health Stroke Scale (NIHSS) on admission; in-hospital outcomes by modified Rankin Scale (mRS) at discharge. Statistical adjustments included covariate adjustment and propensity score matching.

Main Results:

  • Newly diagnosed AF patients (33%) had lower rates of male sex, prior stroke, and pre-stroke oral anticoagulation compared to known AF patients.
  • No significant differences were observed in NIHSS scores on admission or mRS scores at discharge between the two groups.
  • Adjusted analyses confirmed no association between newly diagnosed AF and stroke severity (NIHSS) or in-hospital outcomes (mRS).

Conclusions:

  • Stroke severity and in-hospital outcomes do not significantly differ between newly diagnosed and known AF patients after accounting for relevant factors.
  • The findings underscore the importance of detecting latent AF.
  • Emphasizes the critical role of timely anticoagulation in preventing severe stroke, regardless of AF diagnosis timing.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
55
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
62
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
57
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
82
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
90
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
97